|
Lymphoid Neoplasia
Citations 151-160 of 299 total displayed.
|
Past content
(since Jan 2009):
|
Alcohol consumption and decreased risk of non-Hodgkin lymphoma: role of mTOR dysfunction
- Patrick R. Hagner, Krystyna Mazan-Mamczarz, Bojie Dai, Sharon Corl, X. Frank Zhao, and Ronald B. Gartenhaus
Blood 2009; 113: 5526-5535.
[Abstract]
[Full text]
[PDF]
The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL
- Weimin Ci, Jose M. Polo, Leandro Cerchietti, Rita Shaknovich, Ling Wang, Shao Ning Yang, Kenny Ye, Pedro Farinha, Douglas E. Horsman, Randy D. Gascoyne, Olivier Elemento, and Ari Melnick
Blood 2009; 113: 5536-5548.
[Abstract]
[Full text]
[PDF]
Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell–mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach
- Matthias Niedermeier, Bryan T. Hennessy, Zachary A. Knight, Marina Henneberg, Jianhua Hu, Antonina V. Kurtova, William G. Wierda, Michael J. Keating, Kevan M. Shokat, and Jan A. Burger
Blood 2009; 113: 5549-5557.
[Abstract]
[Full text]
[PDF]
TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia
- Jianhua Yu, Maxim Ershler, Li Yu, Min Wei, Björn Hackanson, Akihiko Yokohama, Takeki Mitsui, Chunhui Liu, Hsiaoyin Mao, Shujun Liu, Zhongfa Liu, Rossana Trotta, Chang-gong Liu, Xiuping Liu, Kun Huang, Jan Visser, Guido Marcucci, Christoph Plass, Alexander V. Belyavsky, and Michael A. Caligiuri
Blood 2009; 113: 5558-5567.
[Abstract]
[Full text]
[PDF]
Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells
- Asish K. Ghosh, Tait D. Shanafelt, Amelia Cimmino, Cristian Taccioli, Stefano Volinia, Chang-gong Liu, George A. Calin, Carlo M. Croce, Denise A. Chan, Amato J. Giaccia, Charla Secreto, Linda E. Wellik, Yean K. Lee, Debabrata Mukhopadhyay, and Neil E. Kay
Blood 2009; 113: 5568-5574.
[Abstract]
[Full text]
[PDF]
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases
- Porcia T. Bradford, Susan S. Devesa, William F. Anderson, and Jorge R. Toro
Blood 2009; 113: 5064-5073.
[Abstract]
[Full text]
[PDF]
Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital
- Jeffrey E. Rubnitz, Mihaela Onciu, Stanley Pounds, Sheila Shurtleff, Xueyuan Cao, Susana C. Raimondi, Frederick G. Behm, Dario Campana, Bassem I. Razzouk, Raul C. Ribeiro, James R. Downing, and Ching-Hon Pui
Blood 2009; 113: 5083-5089.
[Abstract]
[Full text]
[PDF]
A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase–regulated mammalian target of rapamycin activation
- Mamta Gupta, Stacey R. Dillon, Steven C. Ziesmer, Andrew L. Feldman, Thomas E. Witzig, Stephen M. Ansell, James R. Cerhan, and Anne J. Novak
Blood 2009; 113: 5206-5216.
[Abstract]
[Full text]
[PDF]
NPM-ALK inhibits the p53 tumor suppressor pathway in an MDM2 and JNK-dependent manner
- Yu-Xin Cui, Alan Kerby, Fiona Kate Elizabeth McDuff, Hongtao Ye, and Suzanne Dawn Turner
Blood 2009; 113: 5217-5227.
[Abstract]
[Full text]
[PDF]
Biologic sequelae of I B kinase (IKK) inhibition in multiple myeloma: therapeutic implications
- Teru Hideshima, Dharminder Chauhan, Tanyel Kiziltepe, Hiroshi Ikeda, Yutaka Okawa, Klaus Podar, Noopur Raje, Alexei Protopopov, Nikhil C. Munshi, Paul G. Richardson, Ruben D. Carrasco, and Kenneth C. Anderson
Blood 2009; 113: 5228-5236.
[Abstract]
[Full text]
[PDF]
|
|
